Zhixing Wu

机构：University of Liverpool, Hangzhou Normal University, Texas A&M University – Kingsville, Mitchell Institute, University of Florida, Xi’an Jiaotong-Liverpool University, Fuzhou University, Texas A&M University, Florida College · ORCID：0000-0001-5624-8003

发表论文 41 篇 · 总被引 458 次 · h-index 13

代表论文

• Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor (2018 · Acta Pharmacologica Sinica · 被引 47)
• DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting (2025 · Journal of the American Chemical Society · 被引 36)
• Screening of alternative solvent ionic liquids for artemisinin: COSMO-RS prediction and experimental verification (2021 · Journal of Molecular Liquids · 被引 36)
• Ionic liquid screening for dichloromethane absorption by multi-scale simulations (2021 · Separation and Purification Technology · 被引 35)
• Patent landscape of small molecule inhibitors of METTL3 (2020-present) (2024 · Expert Opinion on Therapeutic Patents · 被引 21)
• [Clinical features of coronavirus disease 2019 in children aged <18 years in Jiangxi, China: an analysis of 23 cases]. (2020 · PubMed · 被引 19)